These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Histological validation of iron-oxide and gadolinium based MRI contrast agents in experimental atherosclerosis: the do's and don't's. den Adel B; Bovens SM; te Boekhorst B; Strijkers GJ; Poelmann RE; van der Weerd L; Pasterkamp G Atherosclerosis; 2012 Dec; 225(2):274-80. PubMed ID: 22882907 [TBL] [Abstract][Full Text] [Related]
4. Varying correlation between 18F-fluorodeoxyglucose positron emission tomography and dynamic contrast-enhanced MRI in carotid atherosclerosis: implications for plaque inflammation. Wang J; Liu H; Sun J; Xue H; Xie L; Yu S; Liang C; Han X; Guan Z; Wei L; Yuan C; Zhao X; Chen H Stroke; 2014 Jun; 45(6):1842-5. PubMed ID: 24788973 [TBL] [Abstract][Full Text] [Related]
5. [Iron-oxide-enhanced MR imaging of inflammatory atherosclerotic lesions: overview of experimental and initial clinical results]. Schmitz SA Rofo; 2003 Apr; 175(4):469-76. PubMed ID: 12677500 [TBL] [Abstract][Full Text] [Related]
6. Advances in noninvasive imaging for evaluating clinical risk and guiding therapy in carotid atherosclerosis. Degnan AJ; Young VE; Gillard JH Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):37-53. PubMed ID: 22149525 [TBL] [Abstract][Full Text] [Related]
7. Iron Oxide Nanoparticles as Contrast Agents in Molecular Magnetic Resonance Imaging: Do They Open New Perspectives in Cardiovascular Imaging? Ploussi AG; Gazouli M; Stathis G; Kelekis NL; Efstathopoulos EP Cardiol Rev; 2015; 23(5):229-35. PubMed ID: 25688663 [TBL] [Abstract][Full Text] [Related]
8. FDG-PET imaging of atherosclerosis: Do we know what we see? Sheikine Y; Akram K Atherosclerosis; 2010 Aug; 211(2):371-80. PubMed ID: 20202637 [TBL] [Abstract][Full Text] [Related]
9. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives. Burtea C; Ballet S; Laurent S; Rousseaux O; Dencausse A; Gonzalez W; Port M; Corot C; Vander Elst L; Muller RN Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):e36-48. PubMed ID: 22516067 [TBL] [Abstract][Full Text] [Related]
10. Molecular imaging of atherosclerosis in translational medicine. Perrone-Filardi P; Dellegrottaglie S; Rudd JH; Costanzo P; Marciano C; Vassallo E; Marsico F; Ruggiero D; Petretta MP; Chiariello M; Cuocolo A Eur J Nucl Med Mol Imaging; 2011 May; 38(5):969-75. PubMed ID: 21174089 [TBL] [Abstract][Full Text] [Related]
12. Review of cardiovascular imaging in the journal of nuclear cardiology in 2015. Part 1 of 2: Plaque imaging, positron emission tomography, computed tomography, and magnetic resonance. AlJaroudi WA; Hage FG J Nucl Cardiol; 2016 Feb; 23(1):122-30. PubMed ID: 26542991 [TBL] [Abstract][Full Text] [Related]
13. Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond Bucerius J; Dijkgraaf I; Mottaghy FM; Schurgers LJ Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):251-265. PubMed ID: 30302506 [TBL] [Abstract][Full Text] [Related]
14. Molecular imaging of the atherosclerotic plaque using positron emission tomography. Toor IS; Dweck MR; Newby DE J R Coll Physicians Edinb; 2014; 44(2):139-45. PubMed ID: 24999778 [TBL] [Abstract][Full Text] [Related]
15. [The progress of nuclear medicine and magnetic resonance molecular imaging of atherosclerotic vulnerable plaques]. Zhao ZM; Qin SC Sheng Li Ke Xue Jin Zhan; 2011 Apr; 42(2):86-90. PubMed ID: 21770253 [TBL] [Abstract][Full Text] [Related]
16. Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Fayad ZA; Mani V; Woodward M; Kallend D; Bansilal S; Pozza J; Burgess T; Fuster V; Rudd JH; Tawakol A; Farkouh ME Am Heart J; 2011 Aug; 162(2):214-221.e2. PubMed ID: 21835280 [TBL] [Abstract][Full Text] [Related]
17. Complementary value of cardiac FDG PET and CT for the characterization of atherosclerotic disease. Stolzmann P; Subramanian S; Abdelbaky A; Maurovich-Horvat P; Scheffel H; Tawakol A; Hoffmann U Radiographics; 2011; 31(5):1255-69. PubMed ID: 21918043 [TBL] [Abstract][Full Text] [Related]